A Survival Analysis of Patients with Localized, Asymptomatic Pancreatic Neuroendocrine Tumors: No Surgical Survival Benefit when Examining Appropriately Selected Outcomes-Reference-Cited by-同舟云学术

A Survival Analysis of Patients with Localized, Asymptomatic Pancreatic Neuroendocrine Tumors: No Surgical Survival Benefit when Examining Appropriately Selected Outcomes

Published:2019-11-21 Issue:12 Volume:24 Page:2773-2779
ISSN:1091-255X
Container-title:Journal of Gastrointestinal Surgery
language:en
Short-container-title:J Gastrointest Surg

Author:

Powers Benjamin D.^ORCID,Rothermel Luke D.,Fleming Jason B.,Strosberg Jonathan R.,Anaya Daniel A.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s11605-019-04433-4.pdf

Reference22 articles.

1. Fesinmeyer MD, Austin MA, Li CI, De Roos AJ, Bowen DJ. Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomark Prev 2005;14(7):1766–73. doi:https://doi.org/10.1158/1055-9965.EPI-05-0120.

2. Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y et al. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol 2017;3(10):1335–42. doi:https://doi.org/10.1001/jamaoncol.2017.0589.

3. Zerbi A, Falconi M, Rindi G, Delle Fave G, Tomassetti P, Pasquali C et al. Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases. Am J Gastroenterol 2010;105(6):1421–9. doi:https://doi.org/10.1038/ajg.2009.747.

4. Mansour JC, Chavin K, Morris-Stiff G, Warner SG, Cardona K, Fong ZV et al. Management of asymptomatic, well-differentiated PNETs: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association. HPB : the official journal of the International Hepato Pancreato Biliary Association 2018. https://doi.org/10.1016/j.hpb.2018.09.020.

5. Kulke MH, Anthony LB, Bushnell DL, de Herder WW, Goldsmith SJ, Klimstra DS et al. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas. 2010;39(6):735–52. doi:https://doi.org/10.1097/MPA.0b013e3181ebb168.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Management of Nonfunctional Pancreas Neuroendocrine Tumors;Surgical Clinics of North America;2024-10

2. Pancreatic neuroendocrine tumor: prediction of tumor grades by radiomics models based on ultrasound images;The British Journal of Radiology;2023-09

3. What Is the Role of Lymph Node Resections in Small Islet Tumors?;Advances in Surgery;2023-09

4. Pancreatic resections or observation in management of sporadic non-functioning stage T1 neuroendocrine tumors of the pancreas (PNET) (literature review);Endocrine Surgery;2023-03-11

5. Small nonfunctional pancreatic neuroendocrine neoplasms: Time for a step-up treatment approach?;Endoscopic Ultrasound;2023